LimsPulse
Process-related impurities · Therapeutic protein drug substance and in-process samples

Residual host cell DNA by quantitative PCR (qPCR)

Measures the very small amount of DNA from the host cells left in the purified protein. DNA is extracted from the sample, a sequence that occurs many times in the host genome is amplified by qPCR, and the amount is read from a standard curve of host-cell genomic DNA. The result is reported per mg of product and per dose; a commonly applied limit is 10 ng per dose (typical, from WHO guidance).

  • Biotech & biologics
  • DNA extraction followed by real-time quantitative PCR against a genomic DNA standard curve
  • qPCR
  • Micropipette
  • Centrifuge
  • Water bath
  • Fridge / freezer

Reference: Typical method following the approach of USP <509>, USP <1130> and WHO guidance on cell substrates. Use the kit or in-house assay and limits in your approved procedure.

PRINCIPLE

Why this method works

Real-time PCR copies a short target DNA sequence in repeated heating and cooling cycles, roughly doubling it each cycle. A fluorescent probe or dye reports the amount of product after every cycle. The cycle at which fluorescence crosses a set threshold is the quantification cycle (Cq, also called Ct). The more target DNA at the start, the earlier the curve crosses the threshold: a 10-fold increase in starting DNA lowers Cq by about 3.32 cycles when efficiency is 100%. Plotting Cq against log10 of the amount for a dilution series of host-cell genomic DNA gives a straight-line standard curve, and unknowns are read from it. Assays target highly repeated sequences in the host genome (for example repetitive elements) so that femtogram-to-picogram amounts can be detected. Because protein, salts and detergents in the sample can inhibit PCR, the DNA is first extracted (for example proteinase K digestion followed by magnetic-bead or column purification), and a spiked extraction control measures how much DNA is recovered.

Instruments used

MATERIALS

Reagents & standards

ReagentGrade / specification
Host-cell genomic DNA standardPurified genomic DNA of the production cell line, concentration assigned (e.g. by A260 or fluorescent dye)
Primers and probeSpecific for a repetitive host-genome target (kit or in-house), probe with fluorophore and quencher
qPCR master mixDNA polymerase, dNTPs, buffer and Mg²⁺; may include uracil-DNA glycosylase to limit carry-over
Extraction reagentsProteinase K, lysis buffer, magnetic beads or spin columns, wash and elution buffers
Carrier / diluentDNA-free water or dilution buffer, sometimes with carrier nucleic acid
ControlsNo-template control (NTC), extraction blank, spiked extraction control, internal positive control if used
SAMPLE PREPARATION

Preparing the sample

  1. 01

    Separate areas

    Set up reagents in a clean area, away from DNA standards and products.

  2. 02

    Spike

    Spike one sample aliquot with a known amount of genomic DNA.

  3. 03

    Digest

    Digest protein with proteinase K at the validated temperature.

  4. 04

    Extract

    Purify DNA by magnetic beads or columns; elute in a small volume.

  5. 05

    Set up qPCR

    Add eluates, standards and controls to the master mix in the plate.

  6. 06

    Run & analyse

    Run the cycling program and read Cq against the standard curve.

Procedure

  1. 1Work in a PCR-clean area with dedicated pipettes and filter tips. Keep genomic DNA standards and amplified products away from reagent preparation to avoid contamination.
  2. 2Take a fixed volume of sample (e.g. 200 µL). Prepare a second aliquot spiked with a known amount of host genomic DNA as the extraction recovery control, and an extraction blank of DNA-free water.
  3. 3Add lysis buffer and proteinase K and incubate in a water bath (or heat block) at the validated temperature (typically about 50–60 °C) to digest the protein.
  4. 4Purify the DNA by magnetic-bead or column extraction, wash, and elute into a small volume (e.g. 50 µL), which concentrates it.
  5. 5In the qPCR plate, add master mix with primers and probe, then the genomic DNA standard series, sample eluates, spiked eluate, extraction blank and NTC, usually in triplicate.
  6. 6Seal, spin briefly and run on the qPCR system using the validated cycling program (an initial activation step then about 40 cycles of denaturation and annealing/extension).

Standard preparation

  1. 1Prepare a 10-fold dilution series of host-cell genomic DNA in the validated diluent, typically 5 or more levels (for example 300, 30, 3, 0.3 and 0.03 pg per reaction).
  2. 2Prepare fresh dilutions or use validated frozen aliquots; avoid repeated freeze–thaw.
  3. 3Run the standards in triplicate on every plate.

Notes for analysts

  • Because only a repetitive target is amplified, the result is 'DNA equivalent' to the genomic standard. Very short DNA fragments (below the amplicon length) may not be counted; some regulators also ask about fragment size.
  • Contamination is the main risk: one stray microlitre of concentrated genomic DNA can ruin weeks of work. Keep pre- and post-PCR areas separate and never open used PCR plates in the setup area.
  • Older methods (hybridisation, threshold total-DNA assay) exist; qPCR is now the most common because it is sensitive and specific to the host species.
TEST CONDITIONS

Method parameters (typical)

TargetRepetitive sequence in the host cell genome (kit- or method-specific)
ChemistryHydrolysis (TaqMan-type) probe or validated intercalating dye
Reaction volumee.g. 25–30 µL including 5–10 µL eluate (as validated)
CyclingPolymerase activation, then about 40 cycles of denaturation (~95 °C) and annealing/extension (~60 °C)
Standard curveAt least 5 levels covering the reporting range, triplicate
Reportingpg DNA per mg product and per dose
BEFORE YOU REPORT

System suitability & sequence

ParameterLimit
Standard curve slopeTypically about −3.1 to −3.6 (amplification efficiency about 90–110%)
Correlation (R²)Typically ≥ 0.98 (or as stated in the procedure)
No-template controlNo amplification, or Cq later than the lowest standard by the stated margin
Extraction blankBelow the quantitation limit
Spike recoveryWithin the validated range, commonly 50–150% for residual DNA assays
Replicate precisionCq standard deviation (or %CV of quantity) within the stated limit

Typical sequence

  1. 1Standard curve (5 levels) in triplicate
  2. 2No-template control in triplicate
  3. 3Extraction blank in triplicate
  4. 4Sample eluate in triplicate
  5. 5Spiked sample eluate in triplicate
CALCULATION

Calculation with a worked example

Formula
log10 Q = (Cq − b) / m; Efficiency (%) = (10^(−1/m) − 1) × 100; DNA per dose = (Q / V(sample per reaction)) × V(dose)

Where

Cq
Mean quantification cycle of the sample
m, b
Slope and intercept of the standard curve (Cq against log10 pg)
Q
DNA per reaction (pg) read from the curve
V(sample per reaction)
Original sample volume represented in one reaction (mL)
V(dose)
Volume of drug substance making up one dose (mL)

Given

Standard curve
m = −3.32, b = 27.5 (Cq of 1 pg)
Sample mean Cq
28.4
Extraction
200 µL sample eluted in 50 µL; 5 µL eluate per reaction = 20 µL (0.020 mL) of sample
Product
5 mg/mL; dose 100 mg = 20 mL

Working

  1. 1
    Efficiency = (10^(1/3.32) − 1) × 100 = (2.0008 − 1) × 100 = 100.1%
  2. 2
    log10 Q = (28.4 − 27.5) / (−3.32) = −0.2711, so Q = 10^−0.2711 = 0.536 pg per reaction
  3. 3

    DNA in sample = 0.536 pg / 0.020 mL = 26.8 pg/mL

  4. 4

    Per mg = 26.8 / 5 = 5.36 pg/mg

  5. 5

    Per dose = 26.8 pg/mL × 20 mL = 536 pg = 0.54 ng/dose

Residual host cell DNA = 5.4 pg/mg, about 0.54 ng per 100 mg dose — well below a typical 10 ng/dose limit

ACCEPTANCE CRITERIA

What result passes

  • Residual DNA not more than the product specification limit, usually expressed per dose. A commonly applied limit for products made in continuous cell lines is 10 ng per dose (typical, from WHO guidance); some products justify other limits based on risk and DNA fragment size.
  • All run controls (standard curve, NTC, extraction blank, spike recovery) meet their criteria; otherwise the run is invalid.
  • Results below the quantitation limit reported as less than the LOQ, expressed per mg and per dose.
METHOD VALIDATION

Validation parameters (ICH Q2(R2))

ParameterTypical requirement
SpecificityPrimers amplify the host target only; no signal from product, other cell lines or reagents
AccuracySpike recovery of genomic DNA through extraction in the product matrix
Linearity and rangeStandard curve linear over at least 4–5 logs
PrecisionRepeatability and intermediate precision of quantity, including extraction
LOD / LOQLowest DNA amount detected / quantified reliably, typically femtogram to low-picogram per reaction
RobustnessAnnealing temperature, master mix lot, extraction operator and incubation time
In LimsPulse · Sample Management

Run this method in LimsPulse: specifications and STPs under version control, results calculated and checked against limits, and a signed Certificate of Analysis.

See how